View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Melexis: update on the share buy-back program

Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 22 September 2025, 17.45 hrs CET Further to the initiation of the share buy-back program announced on 10 December 2024, Melexis reports the purchase of 14,249 Melexis shares on Euronext Brussels in the period from 15 to 19 September 2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)15/9/20253,00064.8364.8065.00194,50216/9/20254,00064.6464.4565.00258,58017/9/20255,00064.0163.3064.50320,03418/9/202559164.6764.4565.0038,21719/9/20251,65864.68...

 PRESS RELEASE

Melexis: update over het aandeleninkoopprogramma

Melexis: update over het aandeleninkoopprogramma Persbericht - Gereglementeerde informatie Ieper, België – 22 september 2025, 17.45 uur CET Naar aanleiding van het aandeleninkoopprogramma dat op 10 december 2024 werd aangekondigd, maakt Melexis bekend dat er 14.249 eigen aandelen ingekocht werden op Euronext Brussel tussen 15 en 19 september 2025. InkoopdatumAantal verworven aandelenGemiddelde prijs (€)Laagste prijs (€)Hoogste prijs (€)Aankoop bedrag (€)15/9/20253.00064,8364,8065,00194.50216/9/20254.00064,6464,4565,00258.58017/9/20255.00064,0163,3064,50320.03418/9/202559164,6764,4565,00...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Azelis: Highlights ING Benelux Conference London. Barco: Highlights ING Benelux Conference London. Kinepolis: Highlights ING Benelux Conference London. Melexis: Highlights ING Benelux Conference London. ABN AMRO: Dutch State reducing stake to 20%. ASML: x Mistral, a bet on A.I.. Kinepolis: Cineplex August 2025 box office revenue at 87% of 2019 level, down 27% YoY

 PRESS RELEASE

Melexis: update on the share buy-back program

Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 8 September 2025, 17.45 hrs CET Further to the initiation of the share buy-back program announced on 10 December 2024, Melexis reports the purchase of 1,768 Melexis shares on Euronext Brussels in the period from 1 to 5 September2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)1/9/20250----2/9/20250----3/9/20251,76865.0064.9565.00114,9164/9/20250----5/9/20250----TOTAL1,76865.0064.9565.00114,916 As a result of purchases made since the launc...

 PRESS RELEASE

Melexis: update over het aandeleninkoopprogramma

Melexis: update over het aandeleninkoopprogramma Persbericht - Gereglementeerde informatie Ieper, België – 8 september 2025, 17.45 uur CET Naar aanleiding van het aandeleninkoopprogramma dat op 10 december 2024 werd aangekondigd, maakt Melexis bekend dat er 1.768 eigen aandelen ingekocht werden op Euronext Brussel tussen 1 en 5 september 2025. InkoopdatumAantal verworven aandelenGemiddelde prijs (€)Laagste prijs (€)Hoogste prijs (€)Aankoop bedrag (€)1/9/20250----2/9/20250----3/9/20251.76865,0064,9565,00114.9164/9/20250----5/9/20250----TOTAAL1.76865,0064,9565,00114.916 Als gevolg van aan...

Pierre FerraguÊ
  • Pierre FerraguÊ

Bible 2Q25 – Autos: Semi recovery underway; tangible risks of pull-for...

Today, we are publishing the Autos section of our 28th Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 140 companies we track, providing an update on our key perspectives and convictions. In the coming weeks we will publish sections on Hyperscale & Cloud, Telecom Equipment, PCs, Enterprise IT, Foundry and Semicap Equipment. The auto semiconductor recovery is underway, with revenues up 4% QoQ ...

Marc Hesselink ... (+3)
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Melexis/Slow cyclical recovery/HOLD

Melexis reported a mixed 2Q25 update with the early signs of a market recovery but at the same time disappointing gross margins. We believe that automotive semiconductors will recover further from current lows, but we also expect ongoing uncertainty and low visibility given the major ongoing changes in the auto sector and tariff discussions We reiterate our HOLD rating but increase our target price from €60 to €70 per share given the early signs of an uptrend.

Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
Guy Sips
  • Guy Sips

Melexis 2Q25 release confirming its continued momentum in China and Eu...

We updated our model after 2Q25 showed quarter-on-quarter improvement in both sales and margins. Sales reached € 211.6m, outperforming our estimate of € 200.3m and CSS's forecast of €201.9m. Customers continued to reduce their inventories during the quarter, and Melexis successfully fulfilled the resulting uptick in short-term orders. Melexis noted that 2Q25 sales exceeded expectations, driven by sequential growth in China and EMEA. From an application standpoint, strong performances were record...

Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aedifica: Strong results, guidance reiterated; dsm-firmenich: Symrise 1H25 results; IMCD: Stagnating gross profit leads to disappointing 2Q25 EBITA; JDE Peet's: Full of beans; Just Eat Takeaway: 1H25 results, weak update no impact on takeover; Lotus Bakeries: Peer Mondelez 1Q25 results; Melexis: 2Q25 results, gross margin under pressure; Solvay: 2Q25 in line, subdued outlook no surprise after pre-release; TKH Group: Preview: Under a magnifying glass; Universal Music Group: Spotify 2Q25 ...

Guy Sips ... (+10)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : AED BB, IVA FP, MELE BB, SOLB BB, VPK NA, WKL NA, IMCD...

: AED BB, IVA FP, MELE BB, SOLB BB, VPK NA, WKL NA, IMCD NA, JDEP NA

Guy Sips
  • Guy Sips

Melexis FIRST LOOK: 2Q sales above expectations, FY25 guidance €835m-€...

As anticipated, 2Q25 showed quarter-on-quarter improvement in both sales and margins. Sales reached €211.6m, outperforming our estimate of €200.3m and CSS's forecast of €201.9m. Customers continued to reduce their inventories during the quarter, and Melexis successfully fulfilled the resulting uptick in short-term orders. Melexis noted that 2Q25 sales exceeded expectations, driven by sequential growth in China and EMEA. From an application standpoint, strong performances were recorded in automot...

 PRESS RELEASE

Melexis Q2 2025 results

Melexis Q2 2025 results Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - July 30th, 2025, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: Attachment

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch